2026 Global: Interventional Radiology Market-Competitive Review (2032) report
Description
The 2026 Global: Interventional Radiology Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
Leading the interventional radiology market are global device and imaging manufacturers that shape procedural workflows and patient outcomes. Medtronic, Dublin, Ireland, offers a broad vascular and endovascular portfolio, including catheters, guidewires, stents, and imaging integration that support minimally invasive therapies. Philips, Amsterdam, Netherlands, provides advanced fluoroscopy, ultrasound, and fusion imaging platforms that enhance procedural planning and guidance for complex interventions. Siemens Healthineers, Erlangen, Germany, combines interventional imaging with lab automation and integrated clinical tools to streamline radiology workflows. GE HealthCare, Chicago, United States, delivers comprehensive imaging platforms and contrast-management solutions that support catheter-based therapies and tele-radiology. Terumo, Tokyo, Japan, specializes in core interventional products such as catheters, guidewires, IVUS systems, and supportive devices for peripheral and neurovascular procedures. Together these firms anchor a market increasingly centered on image-guided precision, device interoperability, and data-driven workflow optimization. In tandem, research and regulatory convergence shape faster adoption of safer, image-guided therapies worldwide today.
Boston Scientific, Marlborough, United States, supplies a broad portfolio for interventional radiology including endovascular balloons, stents, microcatheters, embolic agents, and guidewires, all supported by imaging-enhanced guidance tools that streamline procedures. Stryker, Kalamazoo, United States, offers neurovascular and peripheral interventional devices such as microcatheters, flow-diverting stents, and supportive navigation platforms designed to improve catheter access and treatment efficacy. Merit Medical Systems, South Jordan, United States, concentrates on IR and vascular products, offering catheters, introducers, hemostasis devices, and supportive systems used by interventional teams for diagnostic and therapeutic interventions. Cook Medical, Bloomington, United States, delivers an extensive IR portfolio including catheters, embolic materials, drainage devices, and imaging-compatible products that address complex pelvic, hepatic, and peripheral procedures. AngioDynamics, Latham, United States, specializes in peripheral vascular and oncologic therapies, with interventional catheters, thrombus management tools, balloon systems, and accessories that integrate into hybrid IR suites. These firms collectively drive access, efficiency, and outcomes globally.
Collectively, the ten companies outlined dominate the interventional radiology ecosystem, combining imaging prowess, device breadth, and global manufacturing networks that span mature and emerging markets. Their portfolios interlock across diagnostic angiography, vascular intervention, neurovascular therapy, and oncologic imaging, enabling streamlined procedures, reduced procedure times, and expanded access in community hospitals and academic centers alike. Ongoing investments in image-guided analytics, artificial intelligence, and fusion technologies are accelerating product differentiation, while regulatory and payer pressures prioritize safety, traceability, and clinical evidence. Strategic collaborations and acquisitions continue to reshape the landscape, with larger, diversified players absorbing specialty device lines to offer end-to-end solutions. As procedural volumes rise with aging populations and rising prevalence of peripheral vascular disease, these firms are positioned to influence training, adoption curves, and outcomes across varied care settings. For researchers, mapping their capabilities clarifies where innovation is converging, from catheter design to integrated imaging suites and post-procedure monitoring globally.
Leading the interventional radiology market are global device and imaging manufacturers that shape procedural workflows and patient outcomes. Medtronic, Dublin, Ireland, offers a broad vascular and endovascular portfolio, including catheters, guidewires, stents, and imaging integration that support minimally invasive therapies. Philips, Amsterdam, Netherlands, provides advanced fluoroscopy, ultrasound, and fusion imaging platforms that enhance procedural planning and guidance for complex interventions. Siemens Healthineers, Erlangen, Germany, combines interventional imaging with lab automation and integrated clinical tools to streamline radiology workflows. GE HealthCare, Chicago, United States, delivers comprehensive imaging platforms and contrast-management solutions that support catheter-based therapies and tele-radiology. Terumo, Tokyo, Japan, specializes in core interventional products such as catheters, guidewires, IVUS systems, and supportive devices for peripheral and neurovascular procedures. Together these firms anchor a market increasingly centered on image-guided precision, device interoperability, and data-driven workflow optimization. In tandem, research and regulatory convergence shape faster adoption of safer, image-guided therapies worldwide today.
Boston Scientific, Marlborough, United States, supplies a broad portfolio for interventional radiology including endovascular balloons, stents, microcatheters, embolic agents, and guidewires, all supported by imaging-enhanced guidance tools that streamline procedures. Stryker, Kalamazoo, United States, offers neurovascular and peripheral interventional devices such as microcatheters, flow-diverting stents, and supportive navigation platforms designed to improve catheter access and treatment efficacy. Merit Medical Systems, South Jordan, United States, concentrates on IR and vascular products, offering catheters, introducers, hemostasis devices, and supportive systems used by interventional teams for diagnostic and therapeutic interventions. Cook Medical, Bloomington, United States, delivers an extensive IR portfolio including catheters, embolic materials, drainage devices, and imaging-compatible products that address complex pelvic, hepatic, and peripheral procedures. AngioDynamics, Latham, United States, specializes in peripheral vascular and oncologic therapies, with interventional catheters, thrombus management tools, balloon systems, and accessories that integrate into hybrid IR suites. These firms collectively drive access, efficiency, and outcomes globally.
Collectively, the ten companies outlined dominate the interventional radiology ecosystem, combining imaging prowess, device breadth, and global manufacturing networks that span mature and emerging markets. Their portfolios interlock across diagnostic angiography, vascular intervention, neurovascular therapy, and oncologic imaging, enabling streamlined procedures, reduced procedure times, and expanded access in community hospitals and academic centers alike. Ongoing investments in image-guided analytics, artificial intelligence, and fusion technologies are accelerating product differentiation, while regulatory and payer pressures prioritize safety, traceability, and clinical evidence. Strategic collaborations and acquisitions continue to reshape the landscape, with larger, diversified players absorbing specialty device lines to offer end-to-end solutions. As procedural volumes rise with aging populations and rising prevalence of peripheral vascular disease, these firms are positioned to influence training, adoption curves, and outcomes across varied care settings. For researchers, mapping their capabilities clarifies where innovation is converging, from catheter design to integrated imaging suites and post-procedure monitoring globally.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
